UK IVD Industry Finds New Voice And Appetite For Challenges Ahead
Executive Summary
The association of the IVD industry in the UK, BIVDA, is undergoing a rebrand and proactively positioning itself to reinforce the value proposition that diagnostics represent for stakeholders. A new whitepaper on the theme was one of the highlights of an upbeat 2017 annual general meeting, in which Brexit and the EU IVDR for once were not the "stars" of the show.
You may also be interested in...
UK Outlook 2018: IVDs Faces Up To Digital, Pathology Consolidation And IVDR Challenges
UK diagnostics manufacturers face major challenges in adapting to the EU IVDR and to the possible changes that Brexit will bring in regulation, trading conditions, costs and access to talent. In addition, the industry will have to factor in a restructuring of pathology networks and future NHS procurement changes, all while transitioning to digital health-care concepts, says IVD industry association chief Doris-Ann Williams.
UK NICE’s MedTech Scan Will Give NHS Early View Of Innovation
The UK National Institute for Health and Care Excellence is working on a new database of pre-launch-phase medtech products. The aim is to give NHS providers enough time to plan for the uptake of innovative technologies and, generally, to improve the pathway between development and adoption, says NICE medtech programs director Mirella Marlow.
IVD UK Spring Meeting: The Costly But Necessary Route To IVDR Compliance
Second of two articles covering discussion at the spring 2017 meeting of the British In Vitro Diagnostics Association: Not all will survive unscathed as the EU IVD Regulation becomes an operational reality.